Systemic candidiasis produced by oral Candida administration in mice

Insights

Systemic Candida infection was studied in mice. Even with a damaged immune system, Candida albicans was not found in organs 24 hours after oral administration, but appeared later with combined immunosuppressive treatments.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Systemic Candida infection poses a significant threat, often originating from the gastrointestinal tract.
  • Understanding the dynamics of Candida albicans dissemination is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the potential for systemic Candida infection originating from the gastrointestinal tract in a murine model.
  • To determine the conditions under which Candida albicans can disseminate to internal organs after oral administration.

Main Methods:

  • Oral administration of Candida albicans to mice.
  • Assessment of Candida albicans presence in blood and major organs (lungs, spleen, liver, kidneys) at various time points.
  • Evaluation of dissemination under conditions of severe host defense compromise, including combined antibiotic treatment, x-ray irradiation, and dexamethasone administration.

Main Results:

  • Candida albicans was undetectable in blood and organs 24 hours post-oral administration, even with a severely compromised host defense system.
  • Following combined immunosuppressive treatments (antibiotics, x-ray irradiation, dexamethasone) administered 3 and 5 days after initial oral Candida exposure, the fungus became detectable in the liver and kidneys.

Conclusions:

  • Oral Candida administration alone, even in immunocompromised mice, does not readily lead to systemic infection within 24 hours.
  • Combined immunosuppressive therapies significantly increase the risk of Candida albicans dissemination from the gastrointestinal tract to visceral organs like the liver and kidneys.